Design of a serum stability tag for bioactive peptides

Protein and Peptide Letters

Volumn 21, Issue 1, 2014, Pages 32-38

  Jambunathan, Kalyani ^a   Galande, Amit K ^a  

^a SRI INTERNATIONAL   (United States)

Author keywords

Di proline motifs; Fluorogenic probes; Peptide stability; Peptide tags; Proteases; Serum stability

Indexed keywords

AMINO ACID; BRADYKININ; PEPTIDE; PROLINE; PROLYL ENDOPEPTIDASE; PROTEINASE; TETRAPEPTIDE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN MOTIF; PROTEIN STABILITY;

ADULT; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACIDS; ENDOPEPTIDASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, MOLECULAR; PEPTIDES; PROTEIN STABILITY; PROTEOLYSIS; SERUM;

EID: 84891419584     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/09298665113209990069     Document Type: Article

References (24)

1. Vlieghe, P.; Lisowski, V.; Martinez, J.; Khrestchatisky, M. Synthetic therapeutic peptides: science and market. Drug Discov. Today, 2009, 15, 40-56.
2. Craik, D.J.; Fairlie, D.P.; Liras, S.; Price, D. The future of peptidebased drugs. Chem. Biol. Drug. Des., 2013, 81, 136-147.
3. Albericio, F.; Kruger, H.G. Therapeutic peptides. Future. Med. Chem., 2012, 4(12), 1527-1531.
4. Sun, L. Peptide-based drug development. Mod. Chem. Appl., 2013, 1(1), 1000e103.
5. McGregor, D.P. Discovering and improving novel peptide therapeutics. Curr. Opin. Pharmacol., 2008, 8, 616-619.
6. Sato, A.K.; Viswanathan, M.; Kent, R.B.; Wood, C.R. Therapeutic peptides: technological advances driving peptides into development. Curr. Opin. Biotechnol., 1996, 17, 638-642.
7. Tang, L.; Persky, A.M.; Hochhaus, G.; Meibohm, B. Pharmacokinetic aspects of biotechnology products. J. Pharm. Sci., 2004, 93, 2184-2198.
8. Quesada, V.; Ordonez, G.R.; Sanchez, L.M.; Puente, X.S; Lopez-Otin, C. The Degradome database: mammalian proteases and diseases of proteolysis. Nucleic Acids Res., 2009, 37, D239-243.
9. Yi, J.; Liu, Z.; Craft, D.; O'Mullan, P.; Ju, G.; Gelfand, C.A. Intrinsic peptidase activity causes a sequential multi-step reaction (SMSR) in digestion of human plasma peptides. J. Proteome Res., 2008, 7, 5112-5118.
10. Zhu, P.; Bowden, D.; Zhang, D.; Marshall, J.G. Mass spectrometry of peptides and proteins from human blood. Mass Spectrom. Rev., 2011, 30, 685-732.
11. Tugyi, R.; Uray, K.; Ivan, D.; Fellinger, E.; Perkins, A.; Hudecz, F. Partial D-amino acid substitution: improved enzymatic stability and preserved Ab recognition of a MUC2 epitope peptide. PNAS, 2005, 102(2), 413-418.
12. Knappe, D.; Henklein, P.; Hoffman, R.; Hilpert, K. Easy strategy to protect antimicrobial peptides from fast degradation in serum. Antimicrob. Agents Chemother., 2010, 54(9), 4003-4005.
13. Nguyen, L.T.; Chau, J.K.; Perry, N.A.; de Boer, L.; Zaat, S.A.J.; Vogel, H.J. Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs. PloS One, 2010, 5(9), e12684.
14. Cline, L.L.; Waters, M.L. The structure of well-folded β-hairpin peptides promotes resistance to peptidase degradation. Biopolymers (Peptide Science), 2009, 92(6), 502-507.
15. Eldridge, B.; Coley, R.N.; Odegrip, R.; McGregor, D.P.; Fitz-Gerald, K.J.; Ullman, C.G. An in vitro selection strategy for conferring protease resistance to ligand binding peptides. Pro. Eng. Desg. Selec., 2009, 22(11), 691-698.
16. Vanhoof, G.; Goossens, F.; De Meester, I.; Hendriks, D.; Scharpe, S. Proline motifs in peptides and their biological processing. FASEB J., 1995, 9,736-744
17. Walker, J.R.; Altman, R.K.; Warren, J.W.; Altman, E. Using protein-based motifs to stabilize peptides. J. Peptide Res., 2003, 62, 214-226.
18. Watson, D.S.; Jambunathan, K; Askew, D.S.; Kodukula, K.; Galande, A.K. Robust substrate profiling method reveals striking differences in specificities of serum and lung fluid proteases. Biotechniques, 2011, 51, 95-104.
19. Galande, A.K.; Hilderbrand, S.A.; Weissleder, R.; Tung, C.H. Enzyme-targeted fluorescent imaging probes on a multiple antigenic peptide core. J. Med. Chem., 2006, 49, 4715-4720.
20. Jambunathan, K.; Watson, D.S.; Kodukula, K; Galande, A.K. Proteolytic fingerprinting of complex biological samples using combinatorial libraries of fluorogenic probes. Curr. Protoc. Protein Sci., 2012, 70, 21.22.1-21.22.13.
21. Jambunathan, K.; Watson, D.S.; Endsley, A.N.; Kodukula, K.; Galande, A.K. Comparative analysis of substrate specificities of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α. FEBS Lett., 2012, 586, 2507-2512.
22. Diamandis, E.P. Mass Spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol. Cell Proteomics, 2004, 3, 367-378.
23. Murphy, L.J.; Hachey, D.L.; Oates, J.A.; Morrow, J.D.; Brown, N.J. Metabolism of bradykinin in vivo in humans: identification of BK1-5 as a stable plasma peptide metabolite. J. Pharmacol. Exp. Ther., 2000, 294, 263-269.
24. Lopez, A.; Tarrago, T.; Giralt, E. Low molecular weight inhibitors of Prolyl Oligopeptidase: a review of compounds patented from 2003 to 2010. Expert. Opin. Ther. Pat., 2011, 21, 1023-1044.